Текст уведомления здесь

«Skolkovo» and «AstraZeneca» will deal with innovational approach for treating serious diseases

The fund «Skolkovo» and the international biopharmaceutical company «AstraZeneca» will search for innovational approaches for healing ontological and cardiovascular, respiratory and autoimmune diseases, as well as distortions of metabolism and kidneys.
Добавить в закладки
Комментарии

An agreement on the start of an acceleration program under the name «Startup Challenge 2018» has been signed during IX Forum of Regions of Russia: Heath Protection. National Research Nuclear University MEPhI and Siberian State Medical University (SibSMU) will be scientific partners of the project.

«The goal of this enterprise is to define the most promising projects in the field of diagnostics and treatment of socially significant diseases and to support these directions in future to ensure their development and acceleration. The essence of a joint approach is a synergy of technological, investment, commercial, and mentor competencies while choosing the projects, evaluation their risks, as well as supporting teams-winners of the selection stage,» - the chief vice-president of the Innovation Fund «Skolkovo» Kirill Kaem commented on the initiative.

Добавить в закладки
Комментарии
Вам понравилась публикация?
Расскажите, что вы думаете, и мы подберем подходящие материалы